Trifarotene (Aklief) —A New Topical Retinoid for Acne

This Medical Letter review summarizes mechanisms of action and evidence of effects of Aklief, a 0.005% topical cream approved in 2019 for treatment of acne vulgaris in patients aged 9 years or older.

https://jamanetwork.com/journals/jama/fullarticle/2764177

Source: JAMA - April 7, 2020 Category: General Medicine Source Type: research

More News: Acne | General Medicine